Drug Shortage Report for SANDOZ ANAGRELIDE

Last updated on 2023-11-17 History
Report ID 102534
Drug Identification Number 02260107
Brand name SANDOZ ANAGRELIDE
Common or Proper name ANAGRELIDE
Company Name SANDOZ CANADA INCORPORATED
Market Status CANCELLED POST MARKET
Active Ingredient(s) ANAGRELIDE
Strength(s) 0.5MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 100
ATC code L01XX
ATC description OTHER ANTINEOPLASTIC AGENTS
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2019-12-20
Estimated end date Unknown
Actual end date 2020-02-04
Shortage status Resolved
Updated date 2023-11-17
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v14 2023-11-17 French Compare
v13 2023-11-17 English Compare
v12 2021-01-19 French Compare
v11 2021-01-19 English Compare
v10 2020-11-26 French Compare
v9 2020-11-26 English Compare
v8 2020-06-29 French Compare
v7 2020-06-29 English Compare
v6 2020-05-25 French Compare
v5 2020-05-25 English Compare
v4 2020-02-03 French Compare
v3 2020-02-03 English Compare
v2 2020-01-08 French Compare
v1 2020-01-08 English Compare

Showing 1 to 14 of 14